Economic impact of birth-dose Hepatitis B vaccine changes

The medical community is still reeling after a federal advisory panel voted to end the automatic Hepatitis B vaccine at birth, a recommendation that has been in place for more than 30 years. Most of the public-health debate…

Continue Reading